Diversa leverages its proprietary technology in gene library generation and gene evolution to provide robust bio-catalytic solutions across a broad spectrum of chemical industries. The techniques used for enzyme discovery and evolution necessitate the screening of extremely large numbers (6log10 - 9log10 clones) in a high throughput format. Improvements to throughput and sensitivity are key issues in increasing the success rate of these screens. The goal of this project is to develop a general technique to correlate enzyme activity and expression levels in a high throughput and non-intrusive manner. We propose a novel method to expand the range of screenable enzymes and enhance the sensitivity and reproducibility of activity screens. We expect these advances in screening technology to increase Diversa's capacity to produce new enzymes for agricultural, pharmaceutical and chemical applications. These enzymes will enable efficient biochemical reactions to enhance the productivity and reduce the environmental impact of many US companies.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM063355-01
Application #
6338289
Study Section
Special Emphasis Panel (ZRG1-SSS-2 (10))
Program Officer
Jones, Warren
Project Start
2001-05-01
Project End
2002-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
1
Fiscal Year
2001
Total Cost
$119,840
Indirect Cost
Name
Diversa Corporation
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92121